Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy
Research output: Contribution to journal › Journal article › Research › peer-review
Evasion from chemotherapy-induced apoptosis due to p53 loss strongly contributes to drug resistance. Identification of specific targets for the treatment of drug-resistant p53-null tumors would therefore increase the effectiveness of cancer therapy.
| Original language | English |
|---|---|
| Journal | Clinical Cancer Research |
| Volume | 19 |
| Issue number | 14 |
| Pages (from-to) | 3820-31 |
| Number of pages | 12 |
| ISSN | 1078-0432 |
| DOIs | |
| Publication status | Published - 15 Jul 2013 |
ID: 94395223